Exciting News!   This is a start.   May we have more possibilities for understanding, research, marketing, distribution, public health and municipality support... for such products worldwide soon.

"Following our January 2025 newsletter announcement, ACC&D has created a new Website for Egalitte providing more information about Egalitte, a new, temporary immunocontraceptive for male and female dogs that has been developed and approved for use in Chile. Although not yet approved for use in countries other than Chile, ACC&D is excited to continue monitoring for additional information about this product as it becomes available."

Sincerely,

Gary Evans, President  ACC&D Alliance for (nonsurgical) Contraception in Cats and Dogs 

Egalitte®
A temporary immunocontraceptive for male and female dogs, given via subcutaneous injection. Released in late 2024, Egalitte® was developed and tested in Chile, which is the ONLY country where it is currently approved.